| General Information of Drug Metabolite (DM) (ID: DM019133) |
| DM Name |
EGT0001301
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Oxidation - Oxidation |
Bexagliflozin
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Bexagliflozin |
DR3450
|
Phase 3 |
Type-2 diabetes |
|
|
| References |
| 1 |
Metabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
